Ipratropium bromide in children with asthma.
AUTOR(ES)
Mann, N P
RESUMO
Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods. Ipratropium bromide, given in addition to their current treatment, was compared with placebo using a double-blind crossover technique. The period of treatment with ipratropium was associated with a significant reduction in symptoms during both day and night and significantly higher morning peak expiratory flow rates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=459250Documentos Relacionados
- Sodium cromoglycate and ipratropium bromide in exercise-induced asthma.
- Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.
- Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma.
- Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
- Synergism between ipratropium and theophylline in asthma.
